Ray-Coquard I, Leary A, Pignata S, Cropet C, et al. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial. Ann Oncol 2023 May 19:S0923-7534(23)00686-5. doi: 10.1016/j.annonc.2023.
PMID: 37211045